382 related articles for article (PubMed ID: 35766180)
1. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
[TBL] [Abstract][Full Text] [Related]
2. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
Eur Heart J; 2022 Aug; 43(32):e1-e9. PubMed ID: 35441664
[TBL] [Abstract][Full Text] [Related]
3. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
Eur Heart J; 2019 Jun; 40(23):1850-1858. PubMed ID: 30915475
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
Carrick RT; De Marco C; Gasperetti A; Bosman LP; Gourraud JB; Trancuccio A; Mazzanti A; Murray B; Pendleton C; Tichnell C; Tandri H; Zeppenfeld K; Wilde AAM; Davies B; Seifer C; Roberts JD; Healey JS; MacIntyre C; Alqarawi W; Tadros R; Cutler MJ; Targetti M; Calò L; Vitali F; Bertini M; Compagnucci P; Casella M; Dello Russo A; Cappelletto C; De Luca A; Stolfo D; Duru F; Jensen HK; Svensson A; Dahlberg P; Hasselberg NE; Di Marco A; Jordà P; Arbelo E; Moreno Weidmann Z; Borowiec K; Delinière A; Biernacka EK; van Tintelen JP; Platonov PG; Olivotto I; Saguner AM; Haugaa KH; Cox M; Tondo C; Merlo M; Krahn AD; Te Riele ASJM; Wu KC; Calkins H; James CA; Cadrin-Tourigny J
Eur Heart J; 2024 Feb; 45(7):538-548. PubMed ID: 38195003
[TBL] [Abstract][Full Text] [Related]
5. Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy.
Bosman LP; Nielsen Gerlach CL; Cadrin-Tourigny J; Orgeron G; Tichnell C; Murray B; Bourfiss M; van der Heijden JF; Yap SC; Zeppenfeld K; van den Berg MP; Wilde AAM; Asselbergs FW; Tandri H; Calkins H; van Tintelen JP; James CA; Te Riele ASJM
Europace; 2022 Feb; 24(2):296-305. PubMed ID: 34468736
[TBL] [Abstract][Full Text] [Related]
6. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration.
Cadrin-Tourigny J; Bosman LP; Wang W; Tadros R; Bhonsale A; Bourfiss M; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; Van der Heijden JF; Tandri H; Jongbloed JDH; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008509. PubMed ID: 33296238
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
[TBL] [Abstract][Full Text] [Related]
9. External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy.
Baudinaud P; Laredo M; Badenco N; Rouanet S; Waintraub X; Duthoit G; Hidden-Lucet F; Redheuil A; Maupain C; Gandjbakhch E
Can J Cardiol; 2021 Aug; 37(8):1263-1266. PubMed ID: 33675936
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an update.
Cadrin-Tourigny J; Bosman LP; Tadros R; Talajic M; Rivard L; James CA; Khairy P
Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):645-651. PubMed ID: 31422711
[No Abstract] [Full Text] [Related]
13. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
Gasperetti A; Carrick RT; Costa S; Compagnucci P; Bosman LP; Chivulescu M; Tichnell C; Murray B; Tandri H; Tadros R; Rivard L; van den Berg MP; Zeppenfeld K; Wilde AAM; Pompilio G; Carbucicchio C; Dello Russo A; Casella M; Svensson A; Brunckhorst CB; van Tintelen JP; Platonov PG; Haugaa KH; Duru F; Te Riele ASJM; Khairy P; Tondo C; Calkins H; James CA; Saguner AM; Cadrin-Tourigny J
Circulation; 2022 Nov; 146(19):1434-1443. PubMed ID: 36205131
[TBL] [Abstract][Full Text] [Related]
14. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
[TBL] [Abstract][Full Text] [Related]
18. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
Europace; 2023 May; 25(5):. PubMed ID: 37213071
[TBL] [Abstract][Full Text] [Related]
20. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
